Purchase Order 75N95023P00507
Award Date
8/2/23
Potential Completion Date
8/1/24
Potential Value
$17K
Federal Agency
National Institute on Drug Abuse
Awardee
Revvity Health Sciences, Inc.
Ultimate Awardee
Revvity Inc.
NAICS Category
325180 - Other Basic Inorganic Chemical Manufacturing
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to Revvity Health Sciences, Inc. for the purchase of 100,000 "CAMP GI KIT" test kits. The $19,010.65 firm fixed-price purchase order has a completion date of June 27, 2025. The contract does not have a set-aside designation. Revvity Health Sciences is a for-profit manufacturer that has previously provided medical devices and equipment to various federal agencies including the NIH,...
This federal contract award is to Revvity Health Sciences, Inc. for the delivery of a HTRF GTP GI Bind. Kit - 20K PTS to the National Institute on Drug Abuse (NIDA), a civilian agency under the U.S. Department of Health and Human Services. The contract has a firm fixed price of $20,727.50 and a period of performance through November 29, 2024. This award is not associated with a set-aside program. Revvity Health Sciences is a for-profit organization that manufactures medical imaging products...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services. The contract is valued at $10,652.49 and has a period of performance from April 24, 2024 to April 23, 2025. The contract does not have a set-aside designation. Revvity Health Sciences has a history of providing a variety...
This is a $214,952.40 firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Revvity Health Sciences, Inc., a for-profit medical imaging equipment manufacturer. The contract is for the delivery of unspecified laboratory products and services to support research initiatives at the NIH facility in Bethesda, Maryland. This contract does not have a set-aside designation. Revvity Health Sciences, Inc. is a subsidiary of the...
Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, has been awarded a firm fixed price purchase order valued at one hundred forty thousand, four hundred forty-three dollars and twenty-six cents ($140,443.26) by the National Institutes of Health's National Institute of Child Health and Human Development. Under this contract, Revvity will provide one (1) Panoramic MIDI BF Plus FL Advanced imaging system and one (1) HistoQuant software license to support the NIH's...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a firm fixed price purchase order valued at fourteen thousand six hundred fifteen dollars ($14,615) by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract calls for Revvity Health Sciences to provide ALPHALISA HIV P24 (HS) KITS (AMBIS #2184099) with performance taking place in Shelton, Connecticut over the...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The contract, valued at $915,668.54, is for the delivery of unspecified medical imaging products and services to NIDA. The award is not set aside for small businesses. As a prime contractor, Revvity Health Sciences has provided a variety of medical devices...
Revvity Health Sciences, Inc. was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases. The award is for $6,987.32 to provide maintenance agreement services for gold plan coverage with one planned maintenance visit under the contract's period of performance through November 25, 2025. No set-aside designation was used for this procurement. Revvity Health Sciences,...
The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $80,650.96 firm fixed price purchase order contract to Revvity Health Sciences, Inc. for the procurement of a MicroBeta2 plate reader and a cell harvester. The contract has a period of performance through July 29, 2021. This purchase supports NIDA's research and development efforts in brain receptor imaging and investigating promising compounds. The award did not utilize any small business set-aside. Revvity Health...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. The $4,252.18 firm fixed-price purchase order is for the delivery of laboratory equipment to replace a previous requirement. The award does not have a set-aside designation. Revvity Health Sciences has a history of providing medical imaging products and services, such...